Tau Therapy Shows Continued Benefit at 2 Years in Alzheimer's | HappeningNow.news

Health · 4 views

Tau Therapy Shows Continued Benefit at 2 Years in Alzheimer's

Source Summary Published 2h 10m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 4 Community interest
Brief read Under 1 min brief 31 words

Summary

(MedPage Today) -- Diranersen, an investigational antisense oligonucleotide therapy that targets tau, continued to show benefits for 96 weeks, data from the open-label extension of the phase II CELIA trial suggested.

Read original at MedPage Today

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page